Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Lilly inks deal worth up to $1.3B | Women need new CVD guidelines | Atraverse Medical raises $29M | New York Valves 2025
Wednesday, June 18, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

READ MORE >
merger acquisition M&A business
Share on Twitter Share on Facebook Share on Linkedin

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

Share on Twitter Share on Facebook Share on Linkedin
merger acquisition M&A business
The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.
READ MORE >

Cardiology societies should develop separate guidelines for treating female heart patients

Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients need their very own treatment guidelines.

READ MORE >
Janet Wei, MD, Erika J. Glazer Chair in Women’s Cardiovascular Research, Education and Innovation at the Smidt Heart Institute at Cedars-Sinai Hospital, explains the key differences between men and women in cardiovascular disease presentations and disease progression. She said heart disease its the number one cause of death in women and the guidelines cannot be a one size fits all document lumping men and women together, they really need to separate out specific details for women.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology societies should develop separate guidelines for treating female heart patients

Share on Twitter Share on Facebook Share on Linkedin
Janet Wei, MD, Erika J. Glazer Chair in Women’s Cardiovascular Research, Education and Innovation at the Smidt Heart Institute at Cedars-Sinai Hospital, explains the key differences between men and women in cardiovascular disease presentations and disease progression. She said heart disease its the number one cause of death in women and the guidelines cannot be a one size fits all document lumping men and women together, they really need to separate out specific details for women.
Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients need their very own treatment guidelines.
READ MORE >

Atraverse Medical raises $29M to support FDA-approved heart tech

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

READ MORE >
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Share on Twitter Share on Facebook Share on Linkedin

Atraverse Medical raises $29M to support FDA-approved heart tech

Share on Twitter Share on Facebook Share on Linkedin
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.
READ MORE >

Late-breaking clinical trials announced for New York Valves 2025

The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.

READ MORE >
Statue of Liberty New York City healthcare
Share on Twitter Share on Facebook Share on Linkedin

Late-breaking clinical trials announced for New York Valves 2025

Share on Twitter Share on Facebook Share on Linkedin
Statue of Liberty New York City healthcare
The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.
READ MORE >

Featured Articles

Next-day discharge after TAVR is still safe when alternative access is required

Even TAVR patients not treated using transfemoral access can typically go home the very next day. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

Next-day discharge after TAVR is still safe when alternative access is required

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
Even TAVR patients not treated using transfemoral access can typically go home the very next day. 
READ MORE >

AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

READ MORE >
healthcare policy reform government
Share on Twitter Share on Facebook Share on Linkedin

AMA House of Delegates helps cardiology groups influence healthcare policies

Share on Twitter Share on Facebook Share on Linkedin
healthcare policy reform government
American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.
READ MORE >

Why more doctors should pursue business and leadership training

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Why more doctors should pursue business and leadership training

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 
READ MORE >

FDA clears blood clot removal system for treating pulmonary embolism

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

READ MORE >
Inquis Medical Aventus Thrombectomy System
Share on Twitter Share on Facebook Share on Linkedin

FDA clears blood clot removal system for treating pulmonary embolism

Share on Twitter Share on Facebook Share on Linkedin
Inquis Medical Aventus Thrombectomy System
The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.
READ MORE >

In Case You Missed It

The top 25 heart hospitals in the United States

Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? 

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

The top 25 heart hospitals in the United States

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? 
READ MORE >

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.

READ MORE >
soda soft drink coke
Share on Twitter Share on Facebook Share on Linkedin

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

Share on Twitter Share on Facebook Share on Linkedin
soda soft drink coke
“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.
READ MORE >

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.
READ MORE >

In Other News

ChatGPT's medical advice may be deterring women from necessary imaging

The LLM’s responses may be misleading in certain situations, which could pose problems for patients who trust the medical advice it provides.

READ MORE >
shocked surprised social media post defamation
Share on Twitter Share on Facebook Share on Linkedin

ChatGPT's medical advice may be deterring women from necessary imaging

Share on Twitter Share on Facebook Share on Linkedin
shocked surprised social media post defamation
The LLM’s responses may be misleading in certain situations, which could pose problems for patients who trust the medical advice it provides.
READ MORE >

Tau tangles on PET scans may signal impending cognitive decline in asymptomatic individuals

New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Tau tangles on PET scans may signal impending cognitive decline in asymptomatic individuals

Share on Twitter Share on Facebook Share on Linkedin
New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup